Cronos Group Inc. Stock price

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
3.66 CAD +1.10% Intraday chart for Cronos Group Inc. +14.38% +32.13%
Sales 2024 * 137M 101M Sales 2025 * 163M 120M Capitalization 1.4B 1.03B
Net income 2024 * -17M -12.5M Net income 2025 * -10M -7.35M EV / Sales 2024 * 1.52 x
Net cash position 2024 * 1.19B 873M Net cash position 2025 * 1.19B 876M EV / Sales 2025 * 1.25 x
P/E ratio 2024 *
-73.8 x
P/E ratio 2025 *
-134 x
Employees 356
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.29%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.10%
1 week+14.38%
Current month+28.87%
1 month+16.93%
3 months+36.57%
6 months+31.18%
Current year+32.13%
More quotes
1 week
3.25
Extreme 3.25
3.71
1 month
2.56
Extreme 2.56
3.71
Current year
2.56
Extreme 2.56
3.71
1 year
2.15
Extreme 2.145
3.71
3 years
2.15
Extreme 2.145
12.40
5 years
2.15
Extreme 2.145
25.71
10 years
0.14
Extreme 0.14
32.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 37 15-11-05
Director of Finance/CFO 41 22-11-13
Chief Tech/Sci/R&D Officer 41 -
Members of the board TitleAgeSince
Director/Board Member 48 21-06-24
Director/Board Member 57 18-01-31
Director/Board Member 52 16-07-11
More insiders
Date Price Change Volume
24-03-27 3.66 +1.10% 433,348
24-03-26 3.62 +7.42% 540,199
24-03-25 3.37 -5.07% 523,292
24-03-22 3.55 +8.90% 587,943
24-03-21 3.26 +1.87% 176,245

Delayed Quote Toronto S.E., March 27, 2024 at 04:00 pm EDT

More quotes
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, Happy Dance and PEACE+. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd., Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd., and Cronos Israel G.S. Pharmacy Ltd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3.66 CAD
Average target price
3.463 CAD
Spread / Average Target
-5.39%
Consensus
  1. Stock
  2. Equities
  3. Stock Cronos Group Inc. - Toronto S.E.